Abbott’s Established Unit Grows By A Tenth
Led By Increases In Latin America And Asia
Executive Summary
Abbott’s Established Pharmaceuticals business saw double-digit organic growth in the fourth quarter of 2019 on the back of its “unique branded generic strategy in emerging markets,” particularly in Latin America and Asia.